Predicting HBsAg clearance in genotype A chronic hepatitis B using HBsAg epitope profiling: A biomarker for functional cure
Renae Walsh, Rachel Hammond, Lilly Yuen, Joshua Deerain, Tanya O'Donnell, Thomas Leary, Gavin Cloherty, Anuj Gaggar, Kathryn Kitrinos, Mani Subramanian, Darren Wong, Stephen Locarnini
Liver International | WILEY | Published : 2019
Awarded by Gilead Sciences
Gilead Sciences funded and conducted the original GS-US-174-0103 clinical trial, including the collection and storage of serum samples. For the study described here, all clinical data were made available to the investigators. Neither Gilead Sciences nor Abbott Laboratories were involved in the analysis or interpretation of data, the decision to submit for publication, and did not fund the study.